Premium
Ruxolitinib as first‐line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience
Author(s) -
Slostad Jessica,
Hoversten Patrick,
Haddox Candace L.,
Cisak Kamila,
Paludo Jonas,
Tefferi Ayalew
Publication year - 2018
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24971
Subject(s) - hemophagocytic lymphohistiocytosis , ruxolitinib , medicine , pediatrics , immunology , intensive care medicine , bone marrow , myelofibrosis , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom